Clinical trials
Prediction clinical trials
Below are recruiting prediction clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04112927Recruiting
Sound-based test for sleep apnea
This study uses sound recordings to detect sleep apnea while you are awake and during sleep, which could offer a simpler alternative to traditional sleep studies. If you are suspected of having sleep apnea, this trial may help improve diagnosis and monitoring.
Winnipeg, ManitobaAges 18–70 - NCT04119908Recruiting
Test video microscopy to predict bleeding risk
This study uses special video imaging to try to predict when bleeding may happen in certain inherited bleeding disorders. It may help doctors better anticipate bleeding and guide safer care.
Lille, NordAges 18 years+ - NCT04131829RecruitingPhase 1/Phase 2
Brain scan study to predict fluoxetine response in OCD
This study looks at how brain networks change before and after starting fluoxetine (an SSRI antidepressant) in people with obsessive-compulsive disorder (OCD). It also compares these brain scan patterns with people without OCD to help predict who may respond to treatment.
New Haven, ConnecticutAges 18–65 - NCT04000061Recruiting
Tracking heart failure and heart attack progress in hospital
This study looks at how heart problems progress while you’re in the hospital, using your medical information (clinical data). It may help doctors better predict outcomes and improve care for people with heart attacks and heart failure.
BaselAges 18 years+ - NCT03974997Recruiting
Blood test to predict multiple sclerosis flare-ups
This study looks at a blood marker called TWEAK to see if it can signal when multiple sclerosis or its first symptoms might flare up again. If you join, your blood would be checked at regular visits to help predict future inflammation.
MarseilleAges 18 years+ - NCT04014647Recruiting
Blood test to predict heart risk during planned surgery
This trial checks a blood test called NT-proBNP (a marker related to heart stress) to help predict outcomes after planned surgery. It may help doctors identify which patients are at higher risk so they can tailor monitoring and care.
Norwich, NorfolkAges 18 years+ - NCT03835767RecruitingPhase 2
Predicting food allergy from blood IgE levels in eczema patients
This study looks for blood test patterns that may predict whether a child with eczema (atopic dermatitis) is likely to have a food allergy. If you join, you may do supervised oral food challenges with a placebo and the suspected foods to see what triggers symptoms.
Bethesda, MarylandAges 3–21 - NCT03657524Recruiting
Ultrasound heart imaging to help predict trouble weaning off a ventilator
This study uses a special ultrasound of the heart to help predict whether you might fail a trial of breathing on your own after being on a breathing machine. If the test can predict trouble early, clinicians may choose safer weaning plans.
MarseilleAges 18 years+ - NCT03689595Enrolling by invitation
PROMISE study: Predicting myeloma risk in high-risk groups
This study uses a blood test to find early signs of myeloma in people at higher risk, such as those with a family history or African ancestry. It aims to predict who might develop myeloma before symptoms appear.
Boston, MassachusettsAges 30 years+ - NCT03578185Recruiting
Genetic testing to predict response to lung cancer immunotherapy
This study looks at genetic (DNA) information to find a marker that can help predict whether immunotherapy will work for lung cancer. If you’ve already received an immune checkpoint inhibitor, your tumor/genetic data may be analyzed to look for clues that guide treatment.
Seoul, Gangnam-guAges 18 years+ - NCT03594760RecruitingPhase 3
PSMA PET scan study using advanced computer imaging in prostate cancer
This Phase 3 study looks at how a PSMA PET scan can predict how prostate cancer will progress and how well treatment is working. If your doctor at CHUM orders this scan, you may be able to join to help refine better predictions for future patients.
Montreal, QuebecAges 18 years+ - NCT03573791Recruiting
Testing markers to predict chemo-radiation response in rectal cancer
This trial studies lab “biomarkers” (measurable cancer features) to predict whether rectal cancer will resist chemo-radiation before surgery. The goal is to help doctors better choose treatments and avoid ineffective therapy.
Wuhan, HubeiAges 18–75 - NCT03321045RecruitingEarly Phase 1
PET scan to predict benefit from HER2-targeted breast cancer therapy
This early-phase study uses a special PET scan with a drug tagged for imaging to predict how well HER2-targeted treatments will work. It may help doctors choose the most effective therapy for HER2-positive breast cancer.
Birmingham, AlabamaAges 18 years+ - NCT03448926Recruiting
DCIS test registry to guide radiation and drug decisions
This study collects information from people with breast ductal carcinoma in situ (DCIS) to see how a specific lab test (DCISionRT) may help predict who benefits from radiation and/or certain medications. Your results and clinical details are gathered during routine care, not necessarily to change treatment right away.
Scottsdale, ArizonaAges 30–85 - NCT03434392Recruiting
Testing pain-sensing to predict treatment response in chronic pancreatitis
This study uses a special pain-testing method to better predict how people with chronic pancreatitis-related pain (or similar conditions) will respond to treatment. It may help doctors choose therapies that work better for each person’s type of pain.
Baltimore, MarylandAges 18 years+ - NCT03450603Recruiting
Predicting COPD flare-up risk in adults
This study looks at factors that can predict when chronic obstructive pulmonary disease (COPD) will flare up. It may help doctors identify people at higher risk sooner and tailor care to prevent flare-ups.
ShanghaiAges 40 years+ - NCT03369353Enrolling by invitation
Personalized immune testing study for bowel and transplant patients
This study looks at whether a precise lab test can help understand inflammatory bowel disease, functional gut disorders, and immune changes after stem cell transplant or cell therapy. It may help doctors choose better monitoring and treatments based on your immune and gut test results.
Boston, MassachusettsAges Any age - NCT03062748Enrolling by invitation
Study tests how sleep apnea and inflammation relate to risk
This study looks at people with mild to moderate obstructive sleep apnea (OSA) to understand how inflammation and breathing disruption may affect future heart and metabolism risk. It may help explain why some people develop higher risk even with milder sleep apnea.
Hershey, PennsylvaniaAges 18 years+ - NCT03237026Recruiting
Urine tests to predict outcomes in prostate cancer treatment
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
TaipeiAges 30–100 - NCT03010124Recruiting
Biomarker testing in ovarian cancer to guide future treatment
This study looks at tumor tissue from ovarian cancer patients to find “biomarkers,” or lab signals, that may predict how the disease behaves or how it might respond to treatment. You may be asked for a biopsy of the relapsed (coming back) tumor or to use an existing archived tumor sample.
Villejuif, Val de MarneAges 18 years+ - NCT02808260Recruiting
Tracking what predicts abnormal heart rhythms after pacemaker
This study looks for patterns that can predict an abnormal heart rhythm called SCAF in people who have a pacemaker or defibrillator. The goal is to help doctors recognize risk earlier and respond sooner if it happens.
Ottawa, OntarioAges 18 years+ - NCT02576925Recruiting
Predicting the cause of brief double vision episodes
This trial looks at a way to predict what causes short-lasting double vision. It may help doctors choose the right next steps faster after symptoms stop.
ParisAges 18 years+ - NCT01985984Recruiting
Predicting outcomes after head and neck radiotherapy
This study looks at how outcomes may be predicted for people with head and neck cancer who receive radiotherapy. It may help doctors better estimate results and tailor follow-up care.
MaastrichtAges 18 years+ - NCT02043457Recruiting
Study factors that predict long-term weight loss success
This study looks for traits (like health measurements or medical factors) that can help predict who will successfully lose weight and keep it off. It may help researchers personalize weight-loss plans in the future.
Ann Arbor, MichiganAges 15–75
Hear when a new Prediction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prediction?
- Yes. Clin2 currently lists 1,080 recruiting prediction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prediction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prediction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.